Westerdykella reniformis sp. nov., producing the antibiotic metabolites melinacidin IV and chetracin B

35Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

Abstract

Westerdykella reniformis Ebead & Overy sp. nov. is described based on morphology and phylogenetic analyses using ITS, nLSU rDNA, and β-tubulin gene sequences. Westerdykella reniformis is characterized by the production of cleistothecioid ascomata, containing small globose to subglobose asci with 32, aseptate, dark colored, pronouncedly reniform ascospores having a concave central groove. The isolate was obtained from a red alga (Polysiphonia sp.) collected from the tidal zone in Canada at low tide. Organic extracts enriched in extrolites, obtained from fermentation on a rice-based media, inhibited the growth of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecium (VRE), S. warneri, and Proteus vulgaris. Presented here is the identification of the compounds responsible for the observed antimicrobial activity, the taxonomic description of W. reniformis, and a dichotomous key to the known species of Westerdykella based on macro- and micromorphological characters.

Cite

CITATION STYLE

APA

Ebead, G. A., Overy, D. P., Berrué, F., & Kerr, R. G. (2012). Westerdykella reniformis sp. nov., producing the antibiotic metabolites melinacidin IV and chetracin B. IMA Fungus, 3(2), 189–201. https://doi.org/10.5598/imafungus.2012.03.02.11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free